Plenary Session 1101

Precision Medicine in Parkinson’s Disease: The Role of Genetics and Biomarkers

Friday, March 21, 2025
8:00 - 10:00 | Concord Ballroom

This session provides a state-of-the-art overview of Parkinson’s disease genetics and highlights progress in advancing towards disease-modifying treatments.

Chairs:
Nobutaka Hattori, Tokyo
Eng-King Tan, Singapore

Presenters:

Parkinson’s Disease Genetics: Global Distribution, Clinical Features, and Mechanisms
Shen-Yang Lim, Kuala Lumpur

Disease-Modifying Therapies for Parkinson’s Disease
Chin-Hsien Lin, Taipei

Application of Biomarkers in Trials of Disease Modification in Parkinson’s Disease
Taku Hatano, Tokyo

Learning Objectives
At the conclusion of this session, participants should be better able to:

1. Discuss the global distribution, clinical features, and mechanisms of the common genetic forms of Parkinson's disease.
2. Describe the progress of disease-modifying or personalized therapies for Parkinson’s disease based on genetic findings.
3. Recognize biomarkers that could facilitate patient stratification and reflect the disease modification effects of therapies for Parkinson’s disease.

Recommended Audience
Basic Scientists
Clinical Academicians
Non-Physician Health Professionals
Practitioners
Students/Residents/Trainees

Education Level